Please select the option that best describes you:

What oral alternatives would you recommend as opposed to injectable GnRH agonists for those who do not wish to come to clinic due to COVID-19?  

This applies to both de novo cases and patients who have previously received injectable agents.



Answer from: Radiation Oncologist at Community Practice
Comments
Radiation Oncologist at Abramson Cancer Center, University of Pennsylvania
I agree with @Manuj Agarwal. In addition, degarel...
Radiation Oncologist at Huntsman Cancer Institute - University of Utah Health Care
Agreed. It's worth adding that the need for breast...
Sign in or Register to read more